Skip to main navigation Skip to main content Skip to footer For Medicare For Providers For Brokers For Employers Español For Individuals & Families: For Individuals & Families Medical Dental Other Supplemental Explore coverage through work How to Buy Health Insurance Types of Dental Insurance Open Enrollment vs. Special Enrollment See all topics Shop for Medicare plans Member Guide Find a Doctor Log in to myCigna
Home Knowledge Center Wellness Library iobenguane I-131

iobenguane I-131

Pronunciation: EYE oh BEN gwane

Brand: Azedra

What is the most important information I should know about iobenguane I-131?

What is the most important information I should know about iobenguane I-131?

Both men and women using this medicine should use effective birth control to prevent pregnancy. Iobenguane I-131 can harm an unborn baby if the mother or father is receiving this medicine.

If you are a woman, keep using birth control for at least 7 months after your last dose. If you are a man, keep using birth control for at least 4 months after your last dose.

What is iobenguane I-131?

What is iobenguane I-131?

Iobenguane I-131 is a radiopharmaceutical (RAY dee oh far ma SOO tik al) medicine that is used to treat a certain type of adrenal gland tumor (pheochromocytoma).

Iobenguane I-131 is also used to treat a rare type of nerve cell tumor (paraganglioma) that can spread throughout the body.

Iobenguane I-131 is for use in adults and children who are at least 12 years old.

Iobenguane I-131 may also be used for purposes not listed in this medication guide.

What should I discuss with my healthcare provider before taking iobenguane I-131?

What should I discuss with my healthcare provider before taking iobenguane I-131?

Tell your doctor if you have ever had:

  • kidney disease; or
  • if you have routine "INR" or prothrombin time tests.

Using iobenguane I-131 may increase your risk of developing other cancers, such as leukemia. Ask your doctor about this risk.

You may need to have a negative pregnancy test before starting this treatment.

Iobenguane I-131 can harm an unborn baby if the mother or the father is receiving this medicine.

  • If you are a woman, do not use iobenguane I-131 if you are pregnant. Use effective birth control to prevent pregnancy while you are receiving this medicine and for at least 7 months after your last dose.
  • If you are a man, use effective birth control if your sex partner is able to get pregnant. Keep using birth control for at least 4 months after your last dose.
  • Tell your doctor right away if a pregnancy occurs while either the mother or the father is receiving iobenguane I-131.

This medicine may affect fertility (ability to have children) in both men and women. However, it is important to use birth control to prevent pregnancy because iobenguane I-131 can harm an unborn baby.

Do not breast-feed while using this medicine, and for at least 80 days after your last dose.

How should I take iobenguane I-131?

How should I take iobenguane I-131?

Iobenguane I-131 is given as an infusion into a vein. A healthcare provider will give you this injection.

Iobenguane I-131 is usually given within 1 hour before the first in a series of 3 radiologic tests over 5 days. Two additional doses are then given, separated by at least 90 days.

You may be given other medication to help protect your thyroid gland from exposure to the radiation in iobenguane I-131. Keep using this medicine for as long as your doctor has prescribed.

Drink at least 2 liters of liquid on the day before you receive iobenguane I-131, and for 1 week afterward. Follow your doctor's instructions about the types of liquids you should drink. Iobenguane I-131 is radioactive and it can cause dangerous effects on your bladder if it is not properly eliminated from your body through urination.

Expect to urinate often during the first few days after your test. This will help rid your body of the radioactive materials.

Iobenguane I-131 can lower your blood cell counts. Your blood will need to be tested often. Your treatments may be delayed based on the results.

Your blood pressure and kidney function will also need to be checked often.

What happens if I miss a dose?

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your iobenguane I-131 injection.

What happens if I overdose?

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid after receiving iobenguane I-131?

What should I avoid after receiving iobenguane I-131?

For a short time after you receive iobenguane I-131, your body can give off radiation. For at least 1 week after each dose, avoid having contact with other people as much as possible (especially children and pregnant women). Avoid sharing an eating utensil or drinking glass with another person. Wash your hands with soap and water after each time you use the bathroom.

What are the possible side effects of iobenguane I-131?

What are the possible side effects of iobenguane I-131?

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • chest pressure, dry cough, feeling short of breath;
  • easy bruising, unusual bleeding, purple or red spots under your skin;
  • thyroid symptoms --extreme tired feeling, dry skin, joint pain or stiffness, muscle pain or weakness, hoarse voice, feeling more sensitive to cold temperatures, weight gain;
  • low white blood cell counts --fever, mouth sores, skin sores, sore throat, cough, trouble breathing; or
  • low red blood cells (anemia) --pale skin, unusual tiredness, feeling light-headed or short of breath, cold hands and feet.

Common side effects may include:

  • low blood cell counts;
  • feeling tired;
  • nausea, vomiting;
  • dizziness; or
  • low blood pressure (feeling light-headed).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect iobenguane I-131?

What other drugs will affect iobenguane I-131?

Some medicines can interfere with the quality of images produced by iobenguane I-131. Tell your doctor about all your current medicines and any you recently stopped using, especially:

  • St. John's wort;
  • tramadol;
  • blood pressure medication;
  • an antidepressant such as amitriptyline, bupropion, duloxetine, mirtazapine, venlafaxine, Wellbutrin, Cymbalta, Effexor, Pristiq, and others;
  • diet pills, cold or cough medicine; or
  • stimulant medicine such as dextroamphetamine, methylphenidate, Ritalin, Adderall, and others.

This list is not complete and many other drugs may affect iobenguane I-131. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Where can I get more information?

Where can I get more information?

Your doctor or pharmacist can provide more information about iobenguane I-131.

This information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.

<cipublic-spinner variant="large"><span>Loading…</span></cipublic-spinner>

Page Footer

I want to...

Get an ID card File a claim View my claims and EOBs Check coverage under my plan See prescription drug list Find an in-network doctor, dentist, or facility Find a form Find 1095-B tax form information View the Cigna Glossary Contact Cigna

Audiences

Individuals and Families Medicare Employers Brokers Providers

Secure Member Sites

myCigna member portal Health Care Provider portal Cigna for Employers Client Resource Portal Cigna for Brokers

The Cigna Group Information

About The Cigna Group Company Profile Careers Newsroom Investors Suppliers The Cigna Group Third Party Administrators International Evernorth

 Cigna. All rights reserved.

Privacy Legal Product Disclosures Cigna Company Names Customer Rights Accessibility Non-Discrimination Notice Language Assistance [PDF] Report Fraud Sitemap Cookie Settings

Disclaimer

Individual and family medical and dental insurance plans are insured by Cigna Health and Life Insurance Company (CHLIC), Cigna HealthCare of Arizona, Inc., Cigna HealthCare of Illinois, Inc., Cigna HealthCare of Georgia, Inc., Cigna HealthCare of North Carolina, Inc., Cigna HealthCare of South Carolina, Inc., and Cigna HealthCare of Texas, Inc. Group health insurance and health benefit plans are insured or administered by CHLIC, Connecticut General Life Insurance Company (CGLIC), or their affiliates (see a listing of the legal entities that insure or administer group HMO, dental HMO, and other products or services in your state). Accidental Injury, Critical Illness, and Hospital Care plans or insurance policies are distributed exclusively by or through operating subsidiaries of Cigna Corporation, are administered by Cigna Health and Life Insurance Company, and are insured by either (i) Cigna Health and Life Insurance Company (Bloomfield, CT); (ii) Life Insurance Company of North America (“LINA”) (Philadelphia, PA); or (iii) New York Life Group Insurance Company of NY (“NYLGICNY”) (New York, NY), formerly known as Cigna Life Insurance Company of New York. The Cigna name, logo, and other Cigna marks are owned by Cigna Intellectual Property, Inc. LINA and NYLGICNY are not affiliates of Cigna.

All insurance policies and group benefit plans contain exclusions and limitations. For availability, costs and complete details of coverage, contact a licensed agent or Cigna sales representative. This website is not intended for residents of New Mexico.

Selecting these links will take you away from Cigna.com to another website, which may be a non-Cigna website. Cigna may not control the content or links of non-Cigna websites. Details